In the past decade, the drug has become the narcotic of choice for the club and night culture in the United Kingdom and other countries Common street names include K, Special K, Super K, Kit Kat, and Purple.
chromatographic-mass spectrometric (e.g., LC-MS, GC-MS) methods for the initial screen and confirmation. In the past decade, the drug has become
the narcotic of choice for the club and night culture in the United Kingdom and other countries Common street names include K, Special K, Super K, Kit Kat, and Purple. Many party-goers use the drug in tandem with other narcotics (e.g., cannabis, amphetamines, etc.) to intensify the euphoria which can be tailored in a dose dependent fashion. Additionally, some users want to experience the “K-hole” effect, which describes a user entering the “dissociative state” caused by taking large amounts of the drug (100 to 250 mg). Te K-hole can be addictive and highly dangerous to users. Symptoms of this state include paralysis, inability to perceive pain, disorientation, hallucinations, vomiting, chest pains and seizures. Frequent misuse of the drug impairs cognitive ability including recall, memory and overall psychological well-being. The drug has been legally sold in the
United States for human and veterinarian medicine under multiple trade names and include Ketalar® (Pfizer), Ketaject®
68 datia focus
(Phoenix Pharmaceutical), Ketaset® (Wyeth) and Vetalar® (Fort Dodge Animal Health). Edward Domino, one of the fathers of this month’s mystery drug, coined the phrase “Tame the Tiger” in reference to the highly addictive properties of the compound. This month’s mystery drug is ketamine.
Steven Sykes, PhD received his undergraduate degree in Biology at Morehouse College. Soon after graduation, he began working for Employer Solutions at Quest
Diagnostics in Atlanta, GA as a processor and medical technologist. To further his career in the sciences, he pursued a doctorate at the University of Georgia in both the Cellular Biology and Biochemistry Molecular Biology departments. Currently, Dr. Sykes is matriculating through a post-doctoral fellowship at Quest Diagnostics in Lenexa, KS. His present roles include understanding the process of drugs of abuse testing in the different matrices, review of in-house technical procedures and regulations and providing continuing education to laboratory staff.
Spring 2016
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80